1
|
Wang L, Rastegar-Mojarad M, Ji Z, Liu S, Liu K, Moon S, Shen F, Wang Y, Yao L, Davis Iii JM, Liu H. Detecting Pharmacovigilance Signals Combining Electronic Medical Records With Spontaneous Reports: A Case Study of Conventional Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis. Front Pharmacol 2018; 9:875. [PMID: 30131701 PMCID: PMC6090179 DOI: 10.3389/fphar.2018.00875] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2017] [Accepted: 07/19/2018] [Indexed: 12/24/2022] Open
Abstract
Multiple data sources are preferred in adverse drug event (ADEs) surveillance owing to inadequacies of single source. However, analytic methods to monitor potential ADEs after prolonged drug exposure are still lacking. In this study we propose a method aiming to screen potential ADEs by combining FDA Adverse Event Reporting System (FAERS) and Electronic Medical Record (EMR). The proposed method uses natural language processing (NLP) techniques to extract treatment outcome information captured in unstructured text and adopts case-crossover design in EMR. Performances were evaluated using two ADE knowledge bases: Adverse Drug Reaction Classification System (ADReCS) and SIDER. We tested our method in ADE signal detection of conventional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis patients. Findings showed that recall greatly increased when combining FAERS with EMR compared with FAERS alone and EMR alone, especially for flexible mapping strategy. Precision (FAERS + EMR) in detecting ADEs improved using ADReCS as gold standard compared with SIDER. In addition, signals detected from EMR have considerably overlapped with signals detected from FAERS or ADE knowledge bases, implying the importance of EMR for pharmacovigilance. ADE signals detected from EMR and/or FAERS but not in existing knowledge bases provide hypothesis for future study.
Collapse
Affiliation(s)
- Liwei Wang
- Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, United States
| | - Majid Rastegar-Mojarad
- Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, United States
| | - Zhiliang Ji
- State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, China
| | - Sijia Liu
- Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, United States
| | - Ke Liu
- State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, China
| | - Sungrim Moon
- Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, United States
| | - Feichen Shen
- Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, United States
| | - Yanshan Wang
- Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, United States
| | - Lixia Yao
- Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, United States
| | - John M Davis Iii
- Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, United States
| | - Hongfang Liu
- Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, United States
| |
Collapse
|
2
|
Jose A, Cramer AK, Davar K, Gutierrez G. A case of drug-induced lupus erythematosus secondary to trimethoprim/sulfamethoxazole presenting with pleural effusions and pericardial tamponade. Lupus 2016; 26:316-319. [PMID: 27357280 DOI: 10.1177/0961203316657435] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
We report a case of drug-induced lupus erythematosus (DILE) secondary to trimethoprim/sulfamethoxazole (TMP/SMX) in a patient with underlying inflammatory bowel disease (IBD). The initial presentation was with febrile pleural and pericardial effusions followed by cardiac tamponade. The patient was treated with a short course of corticosteroids with complete resolution of symptoms. To our knowledge this is the first reported case of TMP/SMX-induced DILE presenting with life-threatening serositis. When confronted with sterile exudative effusions, clinicians should strongly consider non-infectious etiologies.
Collapse
Affiliation(s)
- A Jose
- Pulmonary, Critical Care and Sleep Medicine Division, The George Washington University, Washington, DC, USA
| | - A K Cramer
- Pulmonary, Critical Care and Sleep Medicine Division, The George Washington University, Washington, DC, USA
| | - K Davar
- Pulmonary, Critical Care and Sleep Medicine Division, The George Washington University, Washington, DC, USA
| | - G Gutierrez
- Pulmonary, Critical Care and Sleep Medicine Division, The George Washington University, Washington, DC, USA
| |
Collapse
|